Impact of weather factors on Mycoplasma pneumoniae pneumonia

D Onozuka1, M Hashizume, A Hagihara

  • 1Department of Planning Information and Administration, Fukuoka Institute of Health and Environmental Sciences, Dazaifu-shi, Fukuoka, Japan. onozuka@fihes.pref.fukuoka.jp

Thorax
|March 26, 2009
PubMed
Abstract

Insights

Rising temperatures and humidity are linked to more Mycoplasma pneumoniae pneumonia cases, particularly in children. This study highlights the impact of weather on respiratory infections.

Area of Science:

  • Environmental Health
  • Epidemiology
  • Pediatrics

Background:

  • Few studies have explored the connection between weather conditions and Mycoplasma pneumoniae pneumonia.
  • Understanding these associations is crucial for public health interventions.

Purpose of the Study:

  • To investigate the relationship between weather factors and Mycoplasma pneumoniae pneumonia incidence.
  • To quantify the impact of temperature and humidity on pneumonia cases.

Main Methods:

  • Time-series analysis of M. pneumoniae pneumonia cases and weather data in Fukuoka, Japan (1999-2007).
  • Adjusted for confounding factors to isolate the effects of weather variables.
  • Included 13,056 reported cases, with 93.7% in individuals under 15.

Main Results:

  • A 1°C increase in average temperature correlated with a 16.9% rise in weekly pneumonia cases.
  • A 1% increase in relative humidity was associated with a 4.1% increase in weekly pneumonia cases.
  • Both associations were statistically significant.

Conclusions:

  • Increased average temperature and relative humidity significantly elevate M. pneumoniae pneumonia cases.
  • Findings suggest weather plays a notable role in the epidemiology of this respiratory infection.
  • Public health strategies may need to consider climate factors for pneumonia prevention.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: